Literature DB >> 25391955

Depression: the best way forward.

Lisa M Monteggia1, Robert C Malenka2, Karl Deisseroth2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25391955     DOI： 10.1038/515200a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

1.  Medicine. The future of psychiatric research: genomes and neural circuits.

Authors:  Huda Akil; Sydney Brenner; Eric Kandel; Kenneth S Kendler; Mary-Claire King; Edward Scolnick; James D Watson; Huda Y Zoghbi
Journal:  Science       Date:  2010-03-26       Impact factor: 47.728

Review 2.  Animal models of neuropsychiatric disorders.

Authors:  Eric J Nestler; Steven E Hyman
Journal:  Nat Neurosci       Date:  2010-09-27       Impact factor: 24.884

3.  Antidepressant effects of ketamine in depressed patients.

Authors:  R M Berman; A Cappiello; A Anand; D A Oren; G R Heninger; D S Charney; J H Krystal
Journal:  Biol Psychiatry       Date:  2000-02-15       Impact factor: 13.382

Review 4.  Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans.

Authors:  Bita Moghaddam; John H Krystal
Journal:  Schizophr Bull       Date:  2012-08-16       Impact factor: 9.306

5.  Revitalizing psychiatric therapeutics.

Authors:  Steven E Hyman
Journal:  Neuropsychopharmacology       Date:  2014-01       Impact factor: 7.853

Review 6.  Synaptic mechanisms underlying rapid antidepressant action of ketamine.

Authors:  Ege T Kavalali; Lisa M Monteggia
Journal:  Am J Psychiatry       Date:  2012-11       Impact factor: 18.112

Review 7.  Illuminating circuitry relevant to psychiatric disorders with optogenetics.

Authors:  Elizabeth E Steinberg; Daniel J Christoffel; Karl Deisseroth; Robert C Malenka
Journal:  Curr Opin Neurobiol       Date:  2014-09-15       Impact factor: 6.627

8.  Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression.

Authors:  Rebecca B Price; Matthew K Nock; Dennis S Charney; Sanjay J Mathew
Journal:  Biol Psychiatry       Date:  2009-07-09       Impact factor: 13.382

9.  Synaptic potentiation onto habenula neurons in the learned helplessness model of depression.

Authors:  Bo Li; Joaquin Piriz; Martine Mirrione; ChiHye Chung; Christophe D Proulx; Daniela Schulz; Fritz Henn; Roberto Malinow
Journal:  Nature       Date:  2011-02-24       Impact factor: 49.962

Review 10.  Circuit dynamics of adaptive and maladaptive behaviour.

Authors:  Karl Deisseroth
Journal:  Nature       Date:  2014-01-16       Impact factor: 49.962
View more
  26 in total

1.  An Electrophysiological Biomarker That May Predict Treatment Response to ECT.

Authors:  Katherine W Scangos; Richard D Weiner; Edward C Coffey; Andrew D Krystal
Journal:  J ECT       Date:  2019-06       Impact factor: 3.635

2.  Computational Analysis of Therapeutic Neuroadaptation to Chronic Antidepressant in a Model of the Monoaminergic Neurotransmitter and Stress Hormone Systems.

Authors:  Mariam B Camacho; Warut D Vijitbenjaronk; Thomas J Anastasio
Journal:  Front Pharmacol       Date:  2019-10-25       Impact factor: 5.810

Review 3.  Targeting Homeostatic Synaptic Plasticity for Treatment of Mood Disorders.

Authors:  Ege T Kavalali; Lisa M Monteggia
Journal:  Neuron       Date:  2020-06-03       Impact factor: 17.173

4.  Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids.

Authors:  Sean D Geddes; Saleha Assadzada; David Lemelin; Alexandra Sokolovski; Richard Bergeron; Samir Haj-Dahmane; Jean-Claude Béïque
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

5.  Editorial (Thematic Selection: Inflammatory and Immune Responses in Depression).

Authors:  Abhay Sharma
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

6.  Proteomic Analysis of the Antidepressant Effects of Shen-Zhi-Ling in Depressed Patients: Identification of Proteins Associated with Platelet Activation and Lipid Metabolism.

Authors:  Chao Chen; Yuan Hu; Xian-Zhe Dong; Xiao-Jiang Zhou; Li-Hua Mu; Ping Liu
Journal:  Cell Mol Neurobiol       Date:  2018-03-21       Impact factor: 5.046

7.  Meranzin Hydrate Improves Depression-Like Behaviors and Hypomotility via Ghrelin and Neurocircuitry.

Authors:  Ya-Lin Liu; Jian-Jun Xu; Lin-Ran Han; Xiang-Fei Liu; Mu-Hai Lin; Yun Wang; Zhe Xiao; Yun-Ke Huang; Ping Ren; Xi Huang
Journal:  Chin J Integr Med       Date:  2022-07-26       Impact factor: 2.626

Review 8.  Rapid-onset antidepressant efficacy of glutamatergic system modulators: the neural plasticity hypothesis of depression.

Authors:  Jing Wang; Liang Jing; Juan-Carlos Toledo-Salas; Lin Xu
Journal:  Neurosci Bull       Date:  2014-12-06       Impact factor: 5.203

Review 9.  Stress effects on the neural substrates of motivated behavior.

Authors:  Nick G Hollon; Lauren M Burgeno; Paul E M Phillips
Journal:  Nat Neurosci       Date:  2015-09-25       Impact factor: 24.884

10.  Catalpol ameliorates depressive-like behaviors in CUMS mice via oxidative stress-mediated NLRP3 inflammasome and neuroinflammation.

Authors:  Ya-Lin Wang; Hao-Ran Wu; Shan-Shan Zhang; Hong-Lei Xiao; Jin Yu; Yuan-Yuan Ma; Yao-Dong Zhang; Qiong Liu
Journal:  Transl Psychiatry       Date:  2021-06-08       Impact factor: 6.222
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.